Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC).

J Thorac Dis · 2021 · PMC8024834 · PMID 33841930

Europe PMC DOI

hedged sentence

0.0420

closest p · 0.8× alpha

0.0420

boldest claim

The sentences

borderline significanceP=0.042actually significant

TCGA dataset analysis of stage I, II and III NSCLC revealed no statistically significant difference in survival between high and low MSI2 mRNA levels among these stages ( Figure 3B ), with borderline significance (P=0.042) at stage III.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.